Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Prof. Dr. Sebastian Suerbaum

Breadcrumb

  1. Home
  2. About Us
  3. Staff
  4. Prof. Dr. Sebastian Suerbaum
Contact
Sebastian Suerbaum

Prof. Dr. Sebastian Suerbaum

Telefonnummer +49 89 2180 72800
E-Mail Send mail
Partner Site
München
Institution
Ludwig-Maximilians-Universität München
Research Area
Community-Acquired Infections at Mucosal Interfaces

Research of the employee

Working Groups Projects
München | Tübingen

CEGIMIR: Center for GI Microbiome Research

The know-how for microbiome analysis coalesces at the Center for GI Microbiome Research (CEGIMIR). The gastrointestinal microbiome, i.e. all the microorganisms in the gastrointestinal tract, plays a key role in the course of infections. Changes in composition, such as those caused by environmental factors or diseases, may, among other things [...]

Read more
München

Genome evolution of Campylobacter bacteria and prediction of antibiotic resistances and virulence

The project deals with the epidemiology of Campylobacter jejuni and Campylobacter coli, the most common acute foodborne diarrhoeal pathogens in humans worldwide. In addition to acute diarrhoeal diseases, these bacteria may also be involved in chronic inflammatory bowel diseases in humans. Antibiotic resistance is currently increasing rapidly in these [...]

Read more
Hannover - Braunschweig | München

Motility inhibitors as novel therapeutic approach against common intestinal pathogens

Helicobacter pylori, Campylobacter jejuni, and Campylobacter coli are among the most widespread bacterial pathogens and responsible for annually hundreds of thousands of cases of diarrhoea, intestinal inflammation, gastric ulcers and stomach cancer worldwide. The research group led by Christine Josenhans at the Ludwig-Maximilians-Universität München (LMU) is developing pathoblockers [...]

Read more
München

Development of a new prophylactic vaccine against Helicobacter pylori

Helicobacter pylori is one of the top 10 bacterial threats listed by the WHO, for which treatment is becoming increasingly difficult due to rising antibiotic resistance. More than half of the world's population is chronically infected with this bacterium. H. pylori is a recognised class I carcinogen responsible for at [...]

Read more
Hannover - Braunschweig | München | Tübingen

HelicoPTER study: Improving the clinical management of H. pylori infections

Almost every second person worldwide is infected with the pathogenic bacterium Helicobacter pylori that causes chronic gastritis. In about 15 percent of infected individuals, gastric inflammation leads to peptic ulcers, and in one to two percent even to stomach cancer. Timely detection and treatment of the infection with antibiotics has [...]

Read more
  • Share on
    • LinkedIn
Print

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Education and Research and the participating federal states